AVALO THERAPEUTICS, INC. Litigation Settlement, Amount Awarded to Other Party
AVALO THERAPEUTICS, INC. (AVTX) reported Litigation Settlement, Amount Awarded to Other Party of $900.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LitigationSettlementAmountAwardedToOtherParty · last filed 2020-11-09
- AVALO THERAPEUTICS, INC. litigation settlement, amount awarded to other party for the quarter ending 2020-09-30 was $900.00K.
| Period end | Litigation Settlement, Amount Awarded to Other Party | Litigation Settlement, Amount Awarded to Other Party 3 month | Litigation Settlement, Amount Awarded to Other Party 9 month |
|---|---|---|---|
| 2020-09-30 | $900.00K 10-Q · filed 2020-11-09 | $900.00K 10-Q · filed 2020-11-09 | |
| 2020-08-28 | $900.00K 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |